Comparison between Concord Biotech IPO and Vishnu Prakash R.Punglia IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Vishnu Prakash R.Punglia IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the Vishnu Prakash R.Punglia IPO is up to ₹308.61 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Vishnu Prakash R.Punglia IPO is ₹99.00 per share.
| Concord Biotech IPO | Vishnu Prakash R.Punglia IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹94.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹99.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹99.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | ₹9.00 per share |
| Market Lot Size | 20 shares | 150 shares |
| Fresh Issue Size | 0 shares | 3,12,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹308.61 Cr |
| OFS Issue Size | 2,09,25,652 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹0.00 Cr |
| Issue Size Total | 2,09,25,652 shares | 3,12,00,000 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹308.61 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while Vishnu Prakash R.Punglia IPO opens on Aug 24, 2023. The closing date of Concord Biotech IPO and Vishnu Prakash R.Punglia IPO is Aug 08, 2023, and Aug 28, 2023, respectively.
| Concord Biotech IPO | Vishnu Prakash R.Punglia IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Aug 23, 2023 |
| Issue Open | Aug 04, 2023 | Aug 24, 2023 |
| Issue Close | Aug 08, 2023 | Aug 28, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Aug 31, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Sep 01, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Sep 04, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Sep 05, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Sep 30, 2023 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Nov 29, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to Vishnu Prakash R.Punglia IPO P/E ratio of 13.61.
| Concord Biotech IPO | Vishnu Prakash R.Punglia IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Standalone)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 90.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 67.81 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 13.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹1234.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | 33.72% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.80 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹10.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 38.31% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in Vishnu Prakash R.Punglia IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 61,80,000 shares in Vishnu Prakash R.Punglia IPO.
| Concord Biotech IPO | Vishnu Prakash R.Punglia IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 92,70,000 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 61,80,000 shares |
| NII | 31,37,348 shares | 46,35,000 shares |
| RII | 73,20,479 shares | 1,08,15,000 shares |
| Employee | 10,000 shares | 3,00,000 shares |
| Others | ||
| Total | 2,09,25,652 shares | 3,12,00,000 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas Vishnu Prakash R.Punglia IPO subscribed 87.82x.
| Concord Biotech IPO | Vishnu Prakash R.Punglia IPO | |
|---|---|---|
| QIB (times) | 67.67x | 171.69x |
| NII (times) | 16.99x | 111.03x |
| Big NII (times) | 19.30x | 112.02x |
| Small NII (times) | 12.37x | 109.07x |
| RII (times) | 3.78x | 32.01x |
| Employee (times) | 24.48x | 12.97x |
| Other (times) | ||
| Total (times) | 24.87x | 87.82x |
